Combination Treatment of Glioblastoma by Low-Dose Radiation and Genistein

Author(s): Zamanian Atefeh, Changizi Vahid, Nedaie Hasan, Amanpour Saeed, Haddadi Mahnaz

Journal Name: Current Radiopharmaceuticals

Volume 9 , Issue 3 , 2016

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Purpose: Gioblastoma multiforme as a chemoresistant and radioresistant malignant cell line needs to novel strategies to treatment. Low-dose hyper-radiosensitivity (LDHRS) seems to be an effective phenomenon to irradiation that can save normal brain fibroblasts. Genistein which is a soy isoflavone can be cytotoxic in some tumor cell lines. So we determined to study the effect of combining these two treatment modalities.

Materials and Methods: After 30 hours incubation with Genistein in different concentrations on U87MG cell line, proliferation and clonogenicity were conducted by both clonogenic and MTT assays. A conventional 2Gy radiation dose was compared with 10 doses of 0.2Gy gamma irradiation with 3 minutes and 1 hour intervals. Finally, concurrent effect of these modalities was assessed.

Results: Based on acquired cell doubling time (30 hours), one doubling time treatment by Genistein could decrease clonogenicity. U87MG cell line exhibited HRS at low dose irradiations. 2Gy irradiation was more effective than ultra-fractionation methods in comparison with control group. All groups with 50uM concentration of Genistein showed decrease in the survival. This decrease compared with control group, in 10x0.2Gy with 3 minutes intervals plus 50uM Genistein was significant and for groups with the same dose of Genistein but along with continuous 2Gy was more significant.

Conclusion: In one day treatment regimen, 10x0.2Gy ultra-fractionation with 3 minutes and 1 hour intervals seems to be less effective than conventional 2Gy irradiation, however adding 50uM Genistein can decrease survival more. Although 2Gy conventional dose plus 50uM Genistein was the most effective regimen.

Keywords: Fractionated radiotherapy, GBM, genistein, glioblastoma, HRS, IRR, Low-dose Hyper-radiosensitivity.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 9
ISSUE: 3
Year: 2016
Page: [258 - 263]
Pages: 6
DOI: 10.2174/1874471009666160813232031
Price: $65

Article Metrics

PDF: 25